Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Lantern Pharma Inc. (LTRN) had Income from Continuous Operations of $-4.18M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.18M |
|
-- |
|
-- |
|
$4.35M |
|
$-4.35M |
|
$0.17M |
|
$-4.18M |
|
$-4.18M |
|
$-4.18M |
|
|
Income from Continuous Operations |
$-4.18M |
$-4.18M |
|
$-4.18M |
|
$-4.35M |
|
$-4.38M |
|
10.83M |
|
10.83M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$13.46M |
|
$0.04M |
|
$0.17M |
|
$13.63M |
|
$4.04M |
|
-- |
|
-- |
|
$4.04M |
|
$9.59M |
|
$9.59M |
|
$9.59M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-12.88M |
|
$12.76M |
|
$0.97M |
|
$7.51M |
|
$8.39M |
|
$0.88M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.57% |
|
-43.57% |
|
-30.66% |
|
-43.57% |
|
$0.87 |
|
$-1.19 |
|
$-1.19 |
|